Clinical Trials at University of Pittsburgh
As of August 2026, 134 paid clinical trials are recruiting at University of Pittsburgh, located at 103 UNIVERSITY PLACE, PITTSBURGH, PA 15260, phone (412) 383-1850 in Pittsburgh, Pennsylvania. Active studies at this site cover conditions such as Breast Cancer, Melanoma and Stroke. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Pittsburgh
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
136 clinical trials at University of Pittsburgh
·Clear filters·Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
A Global Prospective Observational Registry of Patients With Pompe Disease
Terumo Aortic Global Endovascular Registry
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
A Study to Evaluate the SENSE Device's Ability to Detect TBI
Ceribell Delirium Data Collection Study
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
Smartphone-based Intervention for Young Adults With ADHD
tSCS in Children With Spina Bifida
Collaboration for Down Syndrome Progress (CDP)
Imaging CRF X NOP Interactions in Alcohol Use Disorder
Differences in Rest, Emotion, and Arousal Modulation in Youth
Game-Based Intervention to Reduce Alcohol Use Among Youth
Flourish in Schools Pilot Study
Stimulation-Based Modulation of Spinal and Cortical Sensory Pathways
Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injury Whole Blood Test
Topical Cryotherapy and Keloid/Hypertrophic Scars
Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection
Strategy Training for Optimizing Attention for Individuals With Spatial Neglect
Ketamine and Propofol NeuroImaging
Evaluating the Effectiveness of the Health App Recommendation Tool
Kaempferol Absorption and Pharmacokinetics Evaluation
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Remimazolam NeuroImaging
Functional Assessment in Liver Transplantation
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Effects of Operational Naps on Blood Pressure and Performance Among Night Shift Workers
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy
Common conditions studied in Pittsburgh
- Breast Cancer (25 active studies)
- Cancer (19 active studies)
- Melanoma (18 active studies)
- Stroke (17 active studies)
- Endometrial Cancer (16 active studies)
- Ovarian Cancer (16 active studies)
Leading research sponsors in Pittsburgh
- University of Pittsburgh
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- VA Office of Research and Development
Frequently asked questions
How many paid clinical trials are currently recruiting in Pittsburgh?
There are approximately 1,247 recruiting clinical trials in Pittsburgh, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Pittsburgh pay participants?
Most recruiting trials in Pittsburgh compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Pittsburgh?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Pittsburgh?
The most common conditions under active study in Pittsburgh include Breast Cancer (25), Cancer (19), Melanoma (18), Stroke (17), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Pittsburgh?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Pittsburgh on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Pittsburgh?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Pittsburgh?
Recruiting research sites in Pittsburgh include University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Pittsburgh right now?
The largest active categories in Pittsburgh are Cancer & tumors (402), Neurology & pain (84), Cardiovascular (71). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Pittsburgh?
University of Pittsburgh is located at 103 UNIVERSITY PLACE, PITTSBURGH, PA 15260. Use the Google Maps link in the intro above to get directions.
How do I contact University of Pittsburgh?
You can reach University of Pittsburgh by phone at (412) 383-1850. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.